AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 41 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $154 | +569.6% | 100,854 | +622.9% | 0.01% | +550.0% |
Q2 2023 | $23 | -99.9% | 13,952 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $16,000 | -82.4% | 13,704 | -60.6% | 0.00% | -83.3% |
Q1 2022 | $91,000 | -76.1% | 34,769 | -64.4% | 0.01% | -75.0% |
Q4 2021 | $380,000 | -70.7% | 97,802 | -67.1% | 0.05% | -63.6% |
Q3 2021 | $1,296,000 | +234.0% | 297,229 | +203.9% | 0.13% | +200.0% |
Q2 2021 | $388,000 | -64.1% | 97,801 | -52.9% | 0.04% | -75.4% |
Q1 2021 | $1,080,000 | +1267.1% | 207,609 | +1721.1% | 0.18% | +2137.5% |
Q1 2019 | $79,000 | – | 11,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |